Pharmacokinetics and Interactions
An expert discussion on the complex drug-drug interactions, metabolic pathways, and titration requirements for phenytoin and lamotrigine in epilepsy management.
Duration
00:00:37
File size
329kb
Practitioner-Guided Note
Clinicians must employ slow titration for lamotrigine to mitigate rash risk, especially when co-administered with valproate. Note that phenytoin exhibits non-linear kinetics above 12-15 mcg/mL; small dose increments can lead to toxicity.
Key Takeaways
Phenytoin and warfarin mutually increase each other's active plasma levels, requiring frequent monitoring.Phenytoin and carbamazepine can compromise transplant success by reducing the half-life of immunosuppressants.Phenytoin metabolism is saturable, leading to non-linear increases in serum levels above 12-15 mcg/mL.Lamotrigine half-life fluctuates based on co-medication: 12 hours with inducers vs. 60 hours with valproic acid.Slow titration of lamotrigine is essential to prevent serious rashes, particularly in pediatric cases.